Lifecare ASA

Lifecare ASA: Livestream strategic update

Bergen, Norway, 16 May 2025 - Lifecare ASA (LIFE), a medtech company

developing next generation continuous glucose monitoring (CGM) solutions for

diabetes management, announces that CEO Joacim Holter will participate at a

livestream strategic update event at DNB Carnegie Stockholm Monday 19 May

2025, 12:00 CEST.

To register for livestream followed by a Q&A session, please click here.

(https://qcnl.tv/p/jxKBBX8zBAcWvBSJ637J8w)

Key highlights from the presentation:

Diabetes is a trillion-dollar global healthcare challenge

* CGMs the fastest growing diabetes tech segment, representing a USD 30

billion market opportunity

* Within CGMs, implantable solutions represent a USD 5 billion potential

market

Strong value drivers in place 2025-2028

* Set to capitalize on "second mover" advantage, leveraging first mover

regulatory approvals in the US

* Capital efficient path to commercialization with partner-led go-to-market

strategy and minimal additional R&D

* Near-term value inflection points including veterinary market launch late

2025, CE mark in 2026, and European human market launch in 2027

Significant value creation potential

* Peak revenue potential of USD 1 billion + on realistic market assumptions

* Revenue sustainable at high levels long-term assuming conservative market

share in a growing market

* EBITDA margin of 35%+

The presentation is available at: https://lifecare.no/investor/

About us

Lifecare ASA is a medical sensor company developing technology for sensing and

monitoring of various body analytes. Lifecare's focus is to bring the next

generation of Continuous Glucose Monitoring ("CGM") systems to market.

Lifecare enables osmotic pressure as sensing principle. Lifecare's sensor

technology is suitable for identifying and monitoring the occurrence of a wide

range of analytes and molecules in the human body and in pets.

Contacts

For further information, please contact:

Joacim Holter, CEO, [email protected], +47 40 05 90 40

Renete Kaarvik, CFO, [email protected], +47 94 83 82 42

AI Terminal